Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
FONR logo FONR
Upturn stock rating
FONR logo

Fonar Corporation (FONR)

Upturn stock rating
$15.7
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/15/2025: FONR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -1.54%
Avg. Invested days 42
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/15/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 93.69M USD
Price to earnings Ratio 11.9
1Y Target Price -
Price to earnings Ratio 11.9
1Y Target Price -
Volume (30-day avg) -
Beta 1
52 Weeks Range 12.00 - 18.68
Updated Date 06/29/2025
52 Weeks Range 12.00 - 18.68
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.25

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 8.19%
Operating Margin (TTM) 13.48%

Management Effectiveness

Return on Assets (TTM) 3.54%
Return on Equity (TTM) 6.91%

Valuation

Trailing PE 11.9
Forward PE -
Enterprise Value 78089814
Price to Sales(TTM) 0.91
Enterprise Value 78089814
Price to Sales(TTM) 0.91
Enterprise Value to Revenue 0.76
Enterprise Value to EBITDA 3.37
Shares Outstanding 6168460
Shares Floating 6030734
Shares Outstanding 6168460
Shares Floating 6030734
Percent Insiders 2.45
Percent Institutions 49.08

ai summary icon Upturn AI SWOT

Fonar Corporation

stock logo

Company Overview

overview logo History and Background

Fonar Corporation was founded in 1978 by Dr. Raymond Damadian, the inventor of the first MRI scanner. The company's initial focus was on developing and manufacturing whole-body MRI scanners. Over time, Fonar has expanded its product line and services, becoming a player in the diagnostic imaging industry.

business area logo Core Business Areas

  • MRI Scanner Manufacturing: Designs, manufactures, and sells MRI scanners, including upright MRI scanners, which allow patients to be scanned in multiple positions.
  • Diagnostic Imaging Services: Operates diagnostic imaging centers that provide MRI scanning services.
  • Management and Administrative Services: Providing Management services to Medical Facilities.

leadership logo Leadership and Structure

Dr. Raymond Damadian founded the corporation. The organizational structure is typical for a publicly traded company, with a board of directors and a management team responsible for day-to-day operations.

Top Products and Market Share

overview logo Key Offerings

  • Upright MRI Scanner: Fonar is known for its Upright MRI scanner, which allows patients to be scanned in multiple positions, including standing, sitting, bending, and lying down. Market share data for upright MRI scanners specifically is limited, but Fonar is a key player in this niche market. Competitors include Siemens Healthineers, GE Healthcare, Philips Healthcare who have MRI scanners but not in the upright form.
  • Diagnostic Imaging Services: Fonar operates diagnostic imaging centers that provide MRI scanning services. Revenue data is not readily available. Competitors include other diagnostic imaging centers, such as those owned by RadNet (RDNT).

Market Dynamics

industry overview logo Industry Overview

The diagnostic imaging industry is driven by technological advancements, aging populations, and increasing demand for accurate and non-invasive diagnostic procedures. The industry is competitive, with major players investing heavily in research and development.

Positioning

Fonar occupies a niche position in the MRI market with its upright MRI technology. This allows for a competitive advantage in specific clinical applications where positional imaging is valuable.

Total Addressable Market (TAM)

The global MRI market is expected to reach hundreds of millions USD, but the amount is expected to increase. Fonar is positioned to capture a portion of this market. Exact amount of market share Fonar has is difficult to discern, but they are a relatively small player.

Upturn SWOT Analysis

Strengths

  • Unique Upright MRI Technology
  • Established Brand Recognition
  • Proprietary Technology

Weaknesses

  • Smaller Market Share Compared to Major Competitors
  • Limited Product Portfolio
  • Financial Instability (Losses in Current Years)

Opportunities

  • Expanding Diagnostic Imaging Services
  • Developing New MRI Applications
  • Partnerships with Healthcare Providers

Threats

  • Competition from Larger MRI Manufacturers
  • Technological Advancements by Competitors
  • Changes in Healthcare Regulations

Competitors and Market Share

competitor logo Key Competitors

  • Siemens (SIE.DE)
  • GE Healthcare (GE)
  • Philips (PHG)

Competitive Landscape

Fonar's unique upright MRI technology provides a competitive advantage in specific clinical applications. However, the company faces significant competition from larger players with more comprehensive product portfolios and greater resources.

Growth Trajectory and Initiatives

Historical Growth: Fonar's growth has been limited compared to larger players in the MRI market.

Future Projections: Future growth depends on the company's ability to innovate, expand its services, and compete effectively.

Recent Initiatives: Recent initiatives are likely focused on improving operational efficiency and expanding into new markets.

Summary

Fonar Corporation is a niche player in the MRI market, primarily known for its upright MRI technology. While the company possesses a unique competitive advantage with its upright MRI, it faces challenges due to its smaller size and limited resources compared to its competitors. Its success hinges on continued innovation, strategic partnerships, and effective marketing of its unique value proposition. The company would need to work on its financial stability with Losses in current years.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Financial Statements
  • Industry Reports
  • Market Research Reports

Disclaimers:

This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Market share data is estimated due to limited public information and may not be exact.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Fonar Corporation

Exchange NASDAQ
Headquaters Melville, NY, United States
IPO Launch date 1987-01-01
Chairman, President, CEO & Treasurer Mr. Timothy R. Damadian M.D.
Sector Healthcare
Industry Diagnostics & Research
Full time employees 520
Full time employees 520

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, and selling magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. The company offers Upright MRI scanner, allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.